BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andreoli L, Bazzani C, Taraborelli M, Reggia R, Lojacono A, Brucato A, Meroni PL, Tincani A. Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. Autoimmun Rev 2010;10:51-4. [PMID: 20696283 DOI: 10.1016/j.autrev.2010.08.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Taraborelli M, Erkan D. Pregnancy-Related Challenges in Systemic Autoimmune Diseases. J Infus Nurs 2015;38:360-8. [PMID: 26339942 DOI: 10.1097/NAN.0000000000000124] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Meroni P, Shoenfeld Y. Systemic lupus erythematosus and the SLE galaxy. Autoimmunity Reviews 2010;10:1-2. [DOI: 10.1016/j.autrev.2010.09.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
3 Chambers CD, Johnson DL. Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy. Birth Defects Research Part A: Clinical and Molecular Teratology 2012;94:607-11. [DOI: 10.1002/bdra.23033] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
4 Braunstein I, Werth V. Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy: Treatment of autoimmune skin diseases in pregnancy. Dermatol Ther 2013;26:354-63. [DOI: 10.1111/dth.12076] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
5 Gershwin ME, Shoenfeld Y. Chella David: a lifetime contribution in translational immunology. J Autoimmun 2011;37:59-62. [PMID: 21621385 DOI: 10.1016/j.jaut.2011.05.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
6 Tincani A, Dall'Ara F, Lazzaroni MG, Reggia R, Andreoli L. Pregnancy in patients with autoimmune disease: A reality in 2016. Autoimmun Rev 2016;15:975-7. [PMID: 27481037 DOI: 10.1016/j.autrev.2016.07.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
7 Soh MC, Nelson-piercy C. High-risk pregnancy and the rheumatologist. Rheumatology 2015;54:572-87. [DOI: 10.1093/rheumatology/keu394] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
8 Teng YKO, Bredewold EOW, Rabelink TJ, Huizinga TWJ, Eikenboom HCJ, Limper M, Fritsch-Stork RDE, Bloemenkamp KWM, Sueters M. An evidence-based approach to pre-pregnancy counselling for patients with systemic lupus erythematosus. Rheumatology (Oxford) 2018;57:1707-20. [PMID: 29165607 DOI: 10.1093/rheumatology/kex374] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
9 Chang C. Neonatal autoimmune diseases: a critical review. J Autoimmun 2012;38:J223-38. [PMID: 22402339 DOI: 10.1016/j.jaut.2011.11.018] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
10 Beneventi F, Badulli C, Locatelli E, Caporali R, Ramoni V, Cavagnoli C, Simonetta M, Garbin G, Tinelli C, Alpini C, Montecucco C, Martinetti M, Spinillo A. Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases. J Reprod Immunol 2015;110:67-73. [PMID: 26042897 DOI: 10.1016/j.jri.2015.04.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
11 Tüzün E, Huda R, Christadoss P. Complement and cytokine based therapeutic strategies in myasthenia gravis. J Autoimmun 2011;37:136-43. [PMID: 21636248 DOI: 10.1016/j.jaut.2011.05.006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
12 Selmi C. Autoimmunity in 2010. Autoimmun Rev. 2011;10:725-732. [PMID: 21763468 DOI: 10.1016/j.autrev.2011.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
13 Canti V, Castiglioni MT, Rosa S, Franchini S, Sabbadini MG, Manfredi AA, Rovere-querini P. Pregnancy outcomes in patients with systemic autoimmunity. Autoimmunity 2011;45:169-75. [DOI: 10.3109/08916934.2011.593600] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
14 Bleau N, Patenaude V, Abenhaim HA. Risk of Venous Thromboembolic Events in Pregnant Patients With Autoimmune Diseases: A Population-Based Study. Clin Appl Thromb Hemost 2016;22:285-91. [DOI: 10.1177/1076029614553023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
15 Mayer-Pickel K, Eberhard K, Lang U, Cervar-Zivkovic M. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy. Clin Rev Allergy Immunol 2017;53:54-67. [PMID: 27395067 DOI: 10.1007/s12016-016-8569-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
16 Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012;38:J109-19. [PMID: 22079680 DOI: 10.1016/j.jaut.2011.10.003] [Cited by in Crossref: 151] [Cited by in F6Publishing: 142] [Article Influence: 13.7] [Reference Citation Analysis]
17 Coronel-restrepo N, Posso-osorio I, Naranjo-escobar J, Tobón GJ. Autoimmune diseases and their relation with immunological, neurological and endocrinological axes. Autoimmunity Reviews 2017;16:684-92. [DOI: 10.1016/j.autrev.2017.05.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
18 Góralczyk A, Kolossa K, Waszczak-Jeka M, Adamczak R, Jeka S. The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation. Postepy Dermatol Alergol 2020;37:306-12. [PMID: 32774212 DOI: 10.5114/ada.2020.96294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Wan J, Imadojemu S, Werth VP. Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum. Clinics in Dermatology 2016;34:344-52. [DOI: 10.1016/j.clindermatol.2016.02.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
20 Selmi C, Brunetta E, Raimondo MG, Meroni PL. The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev. 2012;11:A531-A537. [PMID: 22155196 DOI: 10.1016/j.autrev.2011.11.024] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
21 Weix J, Förger F, Häupl T, Surbek D, Østensen M, Villiger PM. Influence of pregnancy on the adipocytokine and peroxisome proliferator-activated receptor pathways in peripheral blood mononuclear cells from healthy donors and rheumatoid arthritis patients. Arthritis Rheum 2012;64:2095-103. [PMID: 22231457 DOI: 10.1002/art.34375] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
22 Hazes JM, Coulie PG, Geenen V, Vermeire S, Carbonnel F, Louis E, Masson P, De Keyser F. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. Rheumatology (Oxford). 2011;50:1955-1968. [PMID: 21890617 DOI: 10.1093/rheumatology/ker302] [Cited by in Crossref: 80] [Cited by in F6Publishing: 60] [Article Influence: 7.3] [Reference Citation Analysis]
23 Kittisiam T, Werawatakul Y, Nanagara R, Wantha O. Low prevalence of contraceptive counseling at Srinagarind hospital, Thailand among women of reproductive age with systemic lupus erythematosus. Reprod Health 2013;10:21. [PMID: 23577791 DOI: 10.1186/1742-4755-10-21] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
24 Borchers AT, Gershwin ME. The immune response in Coccidioidomycosis. Autoimmunity Reviews 2010;10:94-102. [DOI: 10.1016/j.autrev.2010.08.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
25 Marchetti T, Cohen M, de Moerloose P. Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications. Clin Dev Immunol 2013;2013:159124. [PMID: 23983765 DOI: 10.1155/2013/159124] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
26 Lazzaroni MG, Crisafulli F, Moschetti L, Semeraro P, Cunha AR, Neto A, Lojacono A, Ramazzotto F, Zanardini C, Zatti S, Airò P, Tincani A, Franceschini F, Andreoli L. Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. Clin Rev Allergy Immunol 2022. [PMID: 35040084 DOI: 10.1007/s12016-021-08910-0] [Reference Citation Analysis]